Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococc

Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Vaccination is a way to prevent infectious diseases such as polio, measles, pneumonia, and others. Vaccines contain severely weakened forms of viruses or bacteria, dead viruses or bacteria, or purified components of viruses or bacteria. After receiving a vaccine, body's immune system can remember bacteria or viruses and can fight off infections more effectively. Vaccines protect people from life-threatening and serious diseases, such as yellow fever, tuberculosis, hepatitis B, and others. There are some people who cannot get vaccinated because they may be too young or sick. Widespread vaccination can help protect such people. When a sufficient number of individuals in a population are immune to a disease, or a large proportion of a population are vaccinated, herd immunity is achieved, that acts by breaking the transmission of infection. Vaccines are mostly administered by injection (parenteral administration), but some are given orally or even nasally (in the case of flu vaccine).
Market Dynamics
Increasing regulatory approvals for vaccines are expected to drive the market growth during the forecast period. For instance, in August 2021, the U.S. Food and Drug Administration approved the Pfizer-BioNTech COVID-19 Vaccine, the first COVID-19 vaccine. The vaccine was developed in partnership by Pfizer Inc., an U.S.-based based pharmaceutical and Biotechnology Company, and BioNTech SE, a biotechnology company. It will be marketed as Comirnaty and will be used for the prevention of COVID-19 disease for individuals with 16 years of age and older. The vaccine will also continue to be available for individuals between 12 and 15 years of age under emergency use authorization (EUA) and for the administration of a third dose to certain immunocompromised people.
Key features of the study:
This report provides an in-depth analysis of the global vaccines market , and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AstraZeneca, GlaxoSmithKline plc., Pfizer Inc., Abbott, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Sanofi, EMERGENT, Astellas Pharma Inc., CSL Limited, Novavax, Serum Institute of India Pvt. Ltd., Bharat Biotech., Indian Immunologicals Ltd., DAIICHI SANKYO COMPANY, LIMITED., and Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market
Detailed Segmentation:
Global Vaccines Market, By Technology:
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
Global Vaccines Market, By Type:
Monovalent Vaccines
Multivalent Vaccines
Global Vaccines Market, By Indication:
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
Global Vaccines Market, By Route of Administration:
Parenteral Administration
Oral Administration
Global Vaccines Market, By Age Group:
Pediatric
Adult
Global Vaccines Market, By Region:
North America
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Country
U.S.
Canada
Latin America
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Country
GCC
Israel
Rest of Middle East
Africa
By Technology
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Therapy
Recombinant Therapy
By Type
Monovalent Vaccines
Multivalent Vaccines
By Indication
Typhoid
Hepatitis
Pneumococcal
DTP
Malaria
Influenza
Human Papilloma Virus
Meningococcal
Polio
Rotavirus
MMR
Varicella
Herpes Zoster
Others
By Route of Administration
Parenteral Administration
Oral Administration
By Age Group
Pediatric
Adult
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
AstraZeneca*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc.
Pfizer Inc.
Abbott
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Sanofi
EMERGENT
Astellas Pharma Inc.
CSL Limited
Novavax
Serum Institute of India Pvt. Ltd.
Bharat Biotech.
Indian Immunologicals Ltd.
DAIICHI SANKYO COMPANY, LIMITED.
Merck & Co., Inc.
“*” marked represents similar segmentation in other categories in the respective section.